Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BIOPSY DIGIT-AM

K-Number: K062039 · 2006-09-11

Decision Date2006-09-11
Product CodeIZH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

BIOPSY DIGIT-AM is the device name listed in this FDA 510(k) record. The listed applicant is Giotto USA, LLC. It received FDA 510(k) clearance on 2006-09-11 under 510(k) number K062039. The device is classified under product code IZH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BIOPSY DIGIT-AM?

BIOPSY DIGIT-AM is a medical device that received FDA 510(k) clearance on 2006-09-11. The listed applicant is Giotto USA, LLC. The 510(k) number is K062039.

When did BIOPSY DIGIT-AM receive FDA 510(k) clearance?

BIOPSY DIGIT-AM received FDA 510(k) clearance on 2006-09-11, under 510(k) number K062039.

Who is the listed applicant for BIOPSY DIGIT-AM?

The FDA 510(k) record lists Giotto USA, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BIOPSY DIGIT-AM?

The FDA product code for BIOPSY DIGIT-AM is IZH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Giotto USA, LLC as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: IZH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑